Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIOZ: Triamcinolone vs Dexamethasone for Inflammatory Macular Edema
NCT02556424Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Jan 2016
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in macular edema, sponsored by CHU de Nantes. Started Jan 2016; status: completed.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT02556424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556424.